Global Next-Generation Gynecological Cancer Diagnostics Supply, Demand and Key Producers, 2023-2029

Page: 115

Published Date: 11 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Next-Generation Gynecological Cancer Diagnostics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Next-Generation Gynecological Cancer Diagnostics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Next-Generation Gynecological Cancer Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Next-Generation Gynecological Cancer Diagnostics that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Next-Generation Gynecological Cancer Diagnostics total market, 2018-2029, (USD Million)
Global Next-Generation Gynecological Cancer Diagnostics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Next-Generation Gynecological Cancer Diagnostics total market, key domestic companies and share, (USD Million)
Global Next-Generation Gynecological Cancer Diagnostics revenue by player and market share 2018-2023, (USD Million)
Global Next-Generation Gynecological Cancer Diagnostics total market by Type, CAGR, 2018-2029, (USD Million)
Global Next-Generation Gynecological Cancer Diagnostics total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Next-Generation Gynecological Cancer Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Invitae Corporation, Konica Minolta, Inc., BGI Genomics, CENTOGENE N.V., Fulgent Genetics, Inc. and Illumina, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Next-Generation Gynecological Cancer Diagnostics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Next-Generation Gynecological Cancer Diagnostics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Next-Generation Gynecological Cancer Diagnostics Market, Segmentation by Type
Ovarian Cancer Diagnosis
Cervical Cancer Diagnosis
Uterine Cancer Diagnosis

Global Next-Generation Gynecological Cancer Diagnostics Market, Segmentation by Application
Hospitals
Clinics
Others

Companies Profiled:
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Invitae Corporation
Konica Minolta, Inc.
BGI Genomics
CENTOGENE N.V.
Fulgent Genetics, Inc.
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Laboratory Corporation of America Holdings
ARUP Laboratories
Myriad Genetics, Inc.
OPKO Health, Inc.
QIAGEN N.V.

Key Questions Answered
1. How big is the global Next-Generation Gynecological Cancer Diagnostics market?
2. What is the demand of the global Next-Generation Gynecological Cancer Diagnostics market?
3. What is the year over year growth of the global Next-Generation Gynecological Cancer Diagnostics market?
4. What is the total value of the global Next-Generation Gynecological Cancer Diagnostics market?
5. Who are the major players in the global Next-Generation Gynecological Cancer Diagnostics market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Next-Generation Gynecological Cancer Diagnostics Introduction
    1.2 World Next-Generation Gynecological Cancer Diagnostics Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Next-Generation Gynecological Cancer Diagnostics Total Market by Region (by Headquarter Location)
        1.3.1 World Next-Generation Gynecological Cancer Diagnostics Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Next-Generation Gynecological Cancer Diagnostics Market Size (2018-2029)
        1.3.3 China Next-Generation Gynecological Cancer Diagnostics Market Size (2018-2029)
        1.3.4 Europe Next-Generation Gynecological Cancer Diagnostics Market Size (2018-2029)
        1.3.5 Japan Next-Generation Gynecological Cancer Diagnostics Market Size (2018-2029)
        1.3.6 South Korea Next-Generation Gynecological Cancer Diagnostics Market Size (2018-2029)
        1.3.7 ASEAN Next-Generation Gynecological Cancer Diagnostics Market Size (2018-2029)
        1.3.8 India Next-Generation Gynecological Cancer Diagnostics Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Next-Generation Gynecological Cancer Diagnostics Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Next-Generation Gynecological Cancer Diagnostics Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.2 World Next-Generation Gynecological Cancer Diagnostics Consumption Value by Region
        2.2.1 World Next-Generation Gynecological Cancer Diagnostics Consumption Value by Region (2018-2023)
        2.2.2 World Next-Generation Gynecological Cancer Diagnostics Consumption Value Forecast by Region (2024-2029)
    2.3 United States Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.4 China Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.5 Europe Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.6 Japan Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.7 South Korea Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.8 ASEAN Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029)
    2.9 India Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029)

3 World Next-Generation Gynecological Cancer Diagnostics Companies Competitive Analysis
    3.1 World Next-Generation Gynecological Cancer Diagnostics Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Next-Generation Gynecological Cancer Diagnostics Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Next-Generation Gynecological Cancer Diagnostics in 2022
        3.2.3 Global Concentration Ratios (CR8) for Next-Generation Gynecological Cancer Diagnostics in 2022
    3.3 Next-Generation Gynecological Cancer Diagnostics Company Evaluation Quadrant
    3.4 Next-Generation Gynecological Cancer Diagnostics Market: Overall Company Footprint Analysis
        3.4.1 Next-Generation Gynecological Cancer Diagnostics Market: Region Footprint
        3.4.2 Next-Generation Gynecological Cancer Diagnostics Market: Company Product Type Footprint
        3.4.3 Next-Generation Gynecological Cancer Diagnostics Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Next-Generation Gynecological Cancer Diagnostics Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Next-Generation Gynecological Cancer Diagnostics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Next-Generation Gynecological Cancer Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Next-Generation Gynecological Cancer Diagnostics Consumption Value Comparison
        4.2.1 United States VS China: Next-Generation Gynecological Cancer Diagnostics Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Next-Generation Gynecological Cancer Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Next-Generation Gynecological Cancer Diagnostics Companies and Market Share, 2018-2023
        4.3.1 United States Based Next-Generation Gynecological Cancer Diagnostics Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Next-Generation Gynecological Cancer Diagnostics Revenue, (2018-2023)
    4.4 China Based Companies Next-Generation Gynecological Cancer Diagnostics Revenue and Market Share, 2018-2023
        4.4.1 China Based Next-Generation Gynecological Cancer Diagnostics Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Next-Generation Gynecological Cancer Diagnostics Revenue, (2018-2023)
    4.5 Rest of World Based Next-Generation Gynecological Cancer Diagnostics Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Next-Generation Gynecological Cancer Diagnostics Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Next-Generation Gynecological Cancer Diagnostics Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Next-Generation Gynecological Cancer Diagnostics Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Ovarian Cancer Diagnosis
        5.2.2 Cervical Cancer Diagnosis
        5.2.3 Uterine Cancer Diagnosis
    5.3 Market Segment by Type
        5.3.1 World Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2018-2023)
        5.3.2 World Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2024-2029)
        5.3.3 World Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Next-Generation Gynecological Cancer Diagnostics Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Clinics
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2018-2023)
        6.3.2 World Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2024-2029)
        6.3.3 World Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Quest Diagnostics Incorporated
        7.1.1 Quest Diagnostics Incorporated Details
        7.1.2 Quest Diagnostics Incorporated Major Business
        7.1.3 Quest Diagnostics Incorporated Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.1.4 Quest Diagnostics Incorporated Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Quest Diagnostics Incorporated Recent Developments/Updates
        7.1.6 Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
    7.2 Thermo Fisher Scientific Inc.
        7.2.1 Thermo Fisher Scientific Inc. Details
        7.2.2 Thermo Fisher Scientific Inc. Major Business
        7.2.3 Thermo Fisher Scientific Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.2.4 Thermo Fisher Scientific Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
        7.2.6 Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
    7.3 Agilent Technologies, Inc.
        7.3.1 Agilent Technologies, Inc. Details
        7.3.2 Agilent Technologies, Inc. Major Business
        7.3.3 Agilent Technologies, Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.3.4 Agilent Technologies, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Agilent Technologies, Inc. Recent Developments/Updates
        7.3.6 Agilent Technologies, Inc. Competitive Strengths & Weaknesses
    7.4 Invitae Corporation
        7.4.1 Invitae Corporation Details
        7.4.2 Invitae Corporation Major Business
        7.4.3 Invitae Corporation Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.4.4 Invitae Corporation Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Invitae Corporation Recent Developments/Updates
        7.4.6 Invitae Corporation Competitive Strengths & Weaknesses
    7.5 Konica Minolta, Inc.
        7.5.1 Konica Minolta, Inc. Details
        7.5.2 Konica Minolta, Inc. Major Business
        7.5.3 Konica Minolta, Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.5.4 Konica Minolta, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Konica Minolta, Inc. Recent Developments/Updates
        7.5.6 Konica Minolta, Inc. Competitive Strengths & Weaknesses
    7.6 BGI Genomics
        7.6.1 BGI Genomics Details
        7.6.2 BGI Genomics Major Business
        7.6.3 BGI Genomics Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.6.4 BGI Genomics Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 BGI Genomics Recent Developments/Updates
        7.6.6 BGI Genomics Competitive Strengths & Weaknesses
    7.7 CENTOGENE N.V.
        7.7.1 CENTOGENE N.V. Details
        7.7.2 CENTOGENE N.V. Major Business
        7.7.3 CENTOGENE N.V. Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.7.4 CENTOGENE N.V. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 CENTOGENE N.V. Recent Developments/Updates
        7.7.6 CENTOGENE N.V. Competitive Strengths & Weaknesses
    7.8 Fulgent Genetics, Inc.
        7.8.1 Fulgent Genetics, Inc. Details
        7.8.2 Fulgent Genetics, Inc. Major Business
        7.8.3 Fulgent Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.8.4 Fulgent Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Fulgent Genetics, Inc. Recent Developments/Updates
        7.8.6 Fulgent Genetics, Inc. Competitive Strengths & Weaknesses
    7.9 Illumina, Inc.
        7.9.1 Illumina, Inc. Details
        7.9.2 Illumina, Inc. Major Business
        7.9.3 Illumina, Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.9.4 Illumina, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Illumina, Inc. Recent Developments/Updates
        7.9.6 Illumina, Inc. Competitive Strengths & Weaknesses
    7.10 F. Hoffmann-La Roche Ltd
        7.10.1 F. Hoffmann-La Roche Ltd Details
        7.10.2 F. Hoffmann-La Roche Ltd Major Business
        7.10.3 F. Hoffmann-La Roche Ltd Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.10.4 F. Hoffmann-La Roche Ltd Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
        7.10.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
    7.11 Laboratory Corporation of America Holdings
        7.11.1 Laboratory Corporation of America Holdings Details
        7.11.2 Laboratory Corporation of America Holdings Major Business
        7.11.3 Laboratory Corporation of America Holdings Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.11.4 Laboratory Corporation of America Holdings Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Laboratory Corporation of America Holdings Recent Developments/Updates
        7.11.6 Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
    7.12 ARUP Laboratories
        7.12.1 ARUP Laboratories Details
        7.12.2 ARUP Laboratories Major Business
        7.12.3 ARUP Laboratories Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.12.4 ARUP Laboratories Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 ARUP Laboratories Recent Developments/Updates
        7.12.6 ARUP Laboratories Competitive Strengths & Weaknesses
    7.13 Myriad Genetics, Inc.
        7.13.1 Myriad Genetics, Inc. Details
        7.13.2 Myriad Genetics, Inc. Major Business
        7.13.3 Myriad Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.13.4 Myriad Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Myriad Genetics, Inc. Recent Developments/Updates
        7.13.6 Myriad Genetics, Inc. Competitive Strengths & Weaknesses
    7.14 OPKO Health, Inc.
        7.14.1 OPKO Health, Inc. Details
        7.14.2 OPKO Health, Inc. Major Business
        7.14.3 OPKO Health, Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.14.4 OPKO Health, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 OPKO Health, Inc. Recent Developments/Updates
        7.14.6 OPKO Health, Inc. Competitive Strengths & Weaknesses
    7.15 QIAGEN N.V.
        7.15.1 QIAGEN N.V. Details
        7.15.2 QIAGEN N.V. Major Business
        7.15.3 QIAGEN N.V. Next-Generation Gynecological Cancer Diagnostics Product and Services
        7.15.4 QIAGEN N.V. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 QIAGEN N.V. Recent Developments/Updates
        7.15.6 QIAGEN N.V. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Next-Generation Gynecological Cancer Diagnostics Industry Chain
    8.2 Next-Generation Gynecological Cancer Diagnostics Upstream Analysis
    8.3 Next-Generation Gynecological Cancer Diagnostics Midstream Analysis
    8.4 Next-Generation Gynecological Cancer Diagnostics Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Next-Generation Gynecological Cancer Diagnostics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Next-Generation Gynecological Cancer Diagnostics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Next-Generation Gynecological Cancer Diagnostics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Next-Generation Gynecological Cancer Diagnostics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Next-Generation Gynecological Cancer Diagnostics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Next-Generation Gynecological Cancer Diagnostics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Next-Generation Gynecological Cancer Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Next-Generation Gynecological Cancer Diagnostics Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Next-Generation Gynecological Cancer Diagnostics Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Next-Generation Gynecological Cancer Diagnostics Players in 2022
    Table 12. World Next-Generation Gynecological Cancer Diagnostics Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Next-Generation Gynecological Cancer Diagnostics Company Evaluation Quadrant
    Table 14. Head Office of Key Next-Generation Gynecological Cancer Diagnostics Player
    Table 15. Next-Generation Gynecological Cancer Diagnostics Market: Company Product Type Footprint
    Table 16. Next-Generation Gynecological Cancer Diagnostics Market: Company Product Application Footprint
    Table 17. Next-Generation Gynecological Cancer Diagnostics Mergers & Acquisitions Activity
    Table 18. United States VS China Next-Generation Gynecological Cancer Diagnostics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Next-Generation Gynecological Cancer Diagnostics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Next-Generation Gynecological Cancer Diagnostics Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Next-Generation Gynecological Cancer Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Next-Generation Gynecological Cancer Diagnostics Revenue Market Share (2018-2023)
    Table 23. China Based Next-Generation Gynecological Cancer Diagnostics Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Next-Generation Gynecological Cancer Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Next-Generation Gynecological Cancer Diagnostics Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Next-Generation Gynecological Cancer Diagnostics Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Next-Generation Gynecological Cancer Diagnostics Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Next-Generation Gynecological Cancer Diagnostics Revenue Market Share (2018-2023)
    Table 29. World Next-Generation Gynecological Cancer Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Next-Generation Gynecological Cancer Diagnostics Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Next-Generation Gynecological Cancer Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Next-Generation Gynecological Cancer Diagnostics Market Size by Application (2024-2029) & (USD Million)
    Table 35. Quest Diagnostics Incorporated Basic Information, Area Served and Competitors
    Table 36. Quest Diagnostics Incorporated Major Business
    Table 37. Quest Diagnostics Incorporated Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 38. Quest Diagnostics Incorporated Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Quest Diagnostics Incorporated Recent Developments/Updates
    Table 40. Quest Diagnostics Incorporated Competitive Strengths & Weaknesses
    Table 41. Thermo Fisher Scientific Inc. Basic Information, Area Served and Competitors
    Table 42. Thermo Fisher Scientific Inc. Major Business
    Table 43. Thermo Fisher Scientific Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 44. Thermo Fisher Scientific Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Thermo Fisher Scientific Inc. Recent Developments/Updates
    Table 46. Thermo Fisher Scientific Inc. Competitive Strengths & Weaknesses
    Table 47. Agilent Technologies, Inc. Basic Information, Area Served and Competitors
    Table 48. Agilent Technologies, Inc. Major Business
    Table 49. Agilent Technologies, Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 50. Agilent Technologies, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Agilent Technologies, Inc. Recent Developments/Updates
    Table 52. Agilent Technologies, Inc. Competitive Strengths & Weaknesses
    Table 53. Invitae Corporation Basic Information, Area Served and Competitors
    Table 54. Invitae Corporation Major Business
    Table 55. Invitae Corporation Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 56. Invitae Corporation Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Invitae Corporation Recent Developments/Updates
    Table 58. Invitae Corporation Competitive Strengths & Weaknesses
    Table 59. Konica Minolta, Inc. Basic Information, Area Served and Competitors
    Table 60. Konica Minolta, Inc. Major Business
    Table 61. Konica Minolta, Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 62. Konica Minolta, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Konica Minolta, Inc. Recent Developments/Updates
    Table 64. Konica Minolta, Inc. Competitive Strengths & Weaknesses
    Table 65. BGI Genomics Basic Information, Area Served and Competitors
    Table 66. BGI Genomics Major Business
    Table 67. BGI Genomics Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 68. BGI Genomics Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. BGI Genomics Recent Developments/Updates
    Table 70. BGI Genomics Competitive Strengths & Weaknesses
    Table 71. CENTOGENE N.V. Basic Information, Area Served and Competitors
    Table 72. CENTOGENE N.V. Major Business
    Table 73. CENTOGENE N.V. Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 74. CENTOGENE N.V. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. CENTOGENE N.V. Recent Developments/Updates
    Table 76. CENTOGENE N.V. Competitive Strengths & Weaknesses
    Table 77. Fulgent Genetics, Inc. Basic Information, Area Served and Competitors
    Table 78. Fulgent Genetics, Inc. Major Business
    Table 79. Fulgent Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 80. Fulgent Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Fulgent Genetics, Inc. Recent Developments/Updates
    Table 82. Fulgent Genetics, Inc. Competitive Strengths & Weaknesses
    Table 83. Illumina, Inc. Basic Information, Area Served and Competitors
    Table 84. Illumina, Inc. Major Business
    Table 85. Illumina, Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 86. Illumina, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Illumina, Inc. Recent Developments/Updates
    Table 88. Illumina, Inc. Competitive Strengths & Weaknesses
    Table 89. F. Hoffmann-La Roche Ltd Basic Information, Area Served and Competitors
    Table 90. F. Hoffmann-La Roche Ltd Major Business
    Table 91. F. Hoffmann-La Roche Ltd Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 92. F. Hoffmann-La Roche Ltd Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. F. Hoffmann-La Roche Ltd Recent Developments/Updates
    Table 94. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
    Table 95. Laboratory Corporation of America Holdings Basic Information, Area Served and Competitors
    Table 96. Laboratory Corporation of America Holdings Major Business
    Table 97. Laboratory Corporation of America Holdings Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 98. Laboratory Corporation of America Holdings Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Laboratory Corporation of America Holdings Recent Developments/Updates
    Table 100. Laboratory Corporation of America Holdings Competitive Strengths & Weaknesses
    Table 101. ARUP Laboratories Basic Information, Area Served and Competitors
    Table 102. ARUP Laboratories Major Business
    Table 103. ARUP Laboratories Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 104. ARUP Laboratories Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. ARUP Laboratories Recent Developments/Updates
    Table 106. ARUP Laboratories Competitive Strengths & Weaknesses
    Table 107. Myriad Genetics, Inc. Basic Information, Area Served and Competitors
    Table 108. Myriad Genetics, Inc. Major Business
    Table 109. Myriad Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 110. Myriad Genetics, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. Myriad Genetics, Inc. Recent Developments/Updates
    Table 112. Myriad Genetics, Inc. Competitive Strengths & Weaknesses
    Table 113. OPKO Health, Inc. Basic Information, Area Served and Competitors
    Table 114. OPKO Health, Inc. Major Business
    Table 115. OPKO Health, Inc. Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 116. OPKO Health, Inc. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. OPKO Health, Inc. Recent Developments/Updates
    Table 118. QIAGEN N.V. Basic Information, Area Served and Competitors
    Table 119. QIAGEN N.V. Major Business
    Table 120. QIAGEN N.V. Next-Generation Gynecological Cancer Diagnostics Product and Services
    Table 121. QIAGEN N.V. Next-Generation Gynecological Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 122. Global Key Players of Next-Generation Gynecological Cancer Diagnostics Upstream (Raw Materials)
    Table 123. Next-Generation Gynecological Cancer Diagnostics Typical Customers
List of Figure
    Figure 1. Next-Generation Gynecological Cancer Diagnostics Picture
    Figure 2. World Next-Generation Gynecological Cancer Diagnostics Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Next-Generation Gynecological Cancer Diagnostics Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Next-Generation Gynecological Cancer Diagnostics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Next-Generation Gynecological Cancer Diagnostics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Next-Generation Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Next-Generation Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Next-Generation Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Next-Generation Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Next-Generation Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Next-Generation Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Next-Generation Gynecological Cancer Diagnostics Revenue (2018-2029) & (USD Million)
    Figure 13. Next-Generation Gynecological Cancer Diagnostics Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Next-Generation Gynecological Cancer Diagnostics Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Next-Generation Gynecological Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Next-Generation Gynecological Cancer Diagnostics by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Next-Generation Gynecological Cancer Diagnostics Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Next-Generation Gynecological Cancer Diagnostics Markets in 2022
    Figure 27. United States VS China: Next-Generation Gynecological Cancer Diagnostics Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Next-Generation Gynecological Cancer Diagnostics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Next-Generation Gynecological Cancer Diagnostics Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Type in 2022
    Figure 31. Ovarian Cancer Diagnosis
    Figure 32. Cervical Cancer Diagnosis
    Figure 33. Uterine Cancer Diagnosis
    Figure 34. World Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Type (2018-2029)
    Figure 35. World Next-Generation Gynecological Cancer Diagnostics Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Next-Generation Gynecological Cancer Diagnostics Market Size Market Share by Application in 2022
    Figure 37. Hospitals
    Figure 38. Clinics
    Figure 39. Others
    Figure 40. Next-Generation Gynecological Cancer Diagnostics Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Next-Generation Gynecological Cancer Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Next-Generation Gynecological Cancer Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 02 Jan 2023

date Medical Care

According to our (Global Info Research) latest study, the global Next-Generation Gynecological Cancer Diagnostics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Next-Generation Gynecological Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Next-Generation Gynecological Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Next-Generation Gynecological Cancer Diagnostics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Next-Generation Gynecological Cancer Diagnostics

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>